Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Nature Reviews. Urology
|
May 13, 2022
Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma
Alexandre Ingels, Riccardo Campi, Umberto Capitanio, et al.
European Urology
|
February 1, 2022
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis
Zhenjie Wu, Qi Chen, Le Qu, et al.
European Urology
|
September 20, 2020
Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter Collaboration
Eduard Roussel, Giovanni Tasso, Riccardo Campi, et al.
Oncotarget
|
January 18, 2015
CD117⁺ cells in the circulation are predictive of advanced prostate cancer
Bethany A Kerr, Ranko Miocinovic, Armine K Smith, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
August 1, 2020
Triggers for delayed intervention in patients with small renal masses undergoing active surveillance: a systematic review
Riccardo Campi, Francesco Sessa, Francesco Corti, et al.
European Urology Open Science
|
April 4, 2024
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
Margaret F Meagher, Andrea Minervini, Maria C Mir, et al.
Minerva Urology and Nephrology
|
October 29, 2021
Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: a systematic review
Riccardo Campi, Alessandro Berni, Daniele Amparore, et al.
Clinical Genitourinary Cancer
|
May 18, 2022
Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry
Margaret F Meagher, Maria C Mir, Riccardo Autorino, et al.
European Urology Oncology
|
May 17, 2020
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma
Eduard Roussel, Riccardo Campi, Alessandro Larcher, et al.
Frontiers in Oncology
|
April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Nature Reviews. Urology
|
May 13, 2022
Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma
Alexandre Ingels, Riccardo Campi, Umberto Capitanio, et al.
European Urology
|
February 1, 2022
Adverse Events of Immune Checkpoint Inhibitors Therapy for Urologic Cancer Patients in Clinical Trials: A Collaborative Systematic Review and Meta-analysis
Zhenjie Wu, Qi Chen, Le Qu, et al.
European Urology
|
September 20, 2020
Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter Collaboration
Eduard Roussel, Giovanni Tasso, Riccardo Campi, et al.
Oncotarget
|
January 18, 2015
CD117⁺ cells in the circulation are predictive of advanced prostate cancer
Bethany A Kerr, Ranko Miocinovic, Armine K Smith, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology
|
August 1, 2020
Triggers for delayed intervention in patients with small renal masses undergoing active surveillance: a systematic review
Riccardo Campi, Francesco Sessa, Francesco Corti, et al.
European Urology Open Science
|
April 4, 2024
Does the Timing of Cytoreductive Nephrectomy Impact Outcomes? Analysis of REMARCC Registry Data for Patients Receiving Tyrosine Kinase Inhibitor Versus Immune Checkpoint Inhibitor Therapy
Margaret F Meagher, Andrea Minervini, Maria C Mir, et al.
Minerva Urology and Nephrology
|
October 29, 2021
Impact of frailty on perioperative and oncologic outcomes in patients undergoing surgery or ablation for renal cancer: a systematic review
Riccardo Campi, Alessandro Berni, Daniele Amparore, et al.
Clinical Genitourinary Cancer
|
May 18, 2022
Impact of Metastasectomy on Cancer Specific and Overall Survival in Metastatic Renal Cell Carcinoma: Analysis of the REMARCC Registry
Margaret F Meagher, Maria C Mir, Riccardo Autorino, et al.
European Urology Oncology
|
May 17, 2020
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma
Eduard Roussel, Riccardo Campi, Alessandro Larcher, et al.
Frontiers in Oncology
|
April 17, 2023
Proposal for a Two-Tier Re-classification of Stage IV/M1 domain of Renal Cell Carcinoma into M1 ("Oligometastatic") and M2 ("Polymetastatic") subdomains: Analysis of the Registry for Metastatic Renal Cell Carcinoma (REMARCC)
Margaret F Meagher, Maria C Mir, Andrea Minervini, et al.
Page
of 6